A collaborative research team from Damanhur University, Al Rayan National College of Medicine, Sohag University, Mansoura University, King Khalid University, and Charles R. Drew University of Medicine and Science has published a new study on BioBran, titled “Biobran/MGN-3: A Promising Natural Strategy for Mitigating Kidney Damage and Immune Modulation During Etoposide Therapy.”

In this preclinical study, researchers investigated BioBran/MGN-3, a rice bran-derived arabinoxylan compound, in an animal model treated with the chemotherapeutic drug etoposide. The study evaluated kidney function and tissue changes, oxidative stress and inflammatory parameters, and immune-related markers associated with etoposide treatment.

Journal: Journal of Bioscience and Applied Research. 2025, 11(2), 395–416
Authors: Ali M. Eldib, Haytham M. Abdellatif, Osman Suliman, Faris M. Elmahdi, Ibrahim H. Babikir, Shimaa B. Hemdan, Reem M. Emam, Mohamed S. El-Gerbed, Mamdooh H. Ghoneum, Attalla F. El-kott, Sara M. Altom.